Nanotechnology and nucleic acid nanoparticles for treatment of metabolic disorders

  • Chu, Dinh-Toi; 
  • Thi, Hue Vu; 
  • Nguyen, Tiep Tien; 
  • Vu, Thuy-Duong; 
  • Thi, Yen Vy Nguyen; 
  • ... Ramakrishna, Suresh; 
  • 외 4명
Citations

SCOPUS

13

초록

Metabolic disorders result from inborn and acquired dysfunction of organs and tissues that are responsible for producing energy in the body. These diseases are now among the most prevalent maladies in the world. Treatment often requires addressing individual conditions, including obesity, diabetes, and liver diseases with a combination of multiple drugs. Accumulating evidence shows that the defects or overexpression of some specific genes in the diseased organ cause such diseases. Therefore, advanced options are required to control them at the molecular level. In this review, we highlight the current approaches of nanotechnologies, especially for delivering exogenous nucleic acid nanoparticles to treat metabolic disorders. We also summarize the mechanisms of how various nucleic acid nanoparticles have been utilized, the trends, and the potential applications of these materials in metabolic disorders. Greater knowledge of nanotechnologies and nucleic acid particles may pave the way to cure these prevalent diseases effectively.

키워드

Gene delivery system; Gene therapy; Metabolic disorders; Non-viral gene vectors; Nucleic acid nanoparticles; alpha actin; antisense oligonucleotide; atorvastatin; carbon nanotube; cholesterol; collagen type 1; curcumin; Ginger extracted nanoparticle; gold nanoparticle; graphene oxide; high density lipoprotein; hydrogel; iron oxide nanoparticle; lipoplex; liposome; low density lipoprotein; messenger RNA; metformin; mevinolin; microRNA; nanocapsule; nanocarrier; nanoparticle; nitric oxide; nucleic acid; plasmid DNA; poly lactic co glycolic acid; polymer; pravastatin; protein kinase; querceti; resveratrol; Salacia chinensis containing gold nanoparticle; silica nanoparticle; silver nanoparticle; simvastatin; small interfering RNA; superparamagnetic iron oxide; thymoquinone; tissue inhibitor of metalloproteinase 1; titanium dioxide; triacylglycerol; unclassified drug; amputation; anisotropy; Article; atherosclerosis; biocompatibility; bloating; blood pressure; bone disease; burn; cancer therapy; cardiovascular disease; coronary artery disease; diabetes mellitus; diabetic wound; drug combination; dr
제목
Nanotechnology and nucleic acid nanoparticles for treatment of metabolic disorders
저자
Chu, Dinh-Toi; Thi, Hue Vu; Nguyen, Tiep Tien; Vu, Thuy-Duong; Thi, Yen Vy Nguyen; Mani, Indra; Gohil, Nisarg; Bhattacharjee, Gargi; Ramakrishna, Suresh; Singh, Vijai
DOI
10.1016/j.onano.2023.100181
발행일
2023-09
유형
Article
저널명
OpenNano
권
13
페이지
1 ~ 10

파일 다운로드

Thumbnail